... the biotechnology company's stock worth $249,000 after acquiring an additional 5,492 shares during the last quarter. Ardsley Advisory Partners bought a new stake in Eiger Biopharmaceuticals during the second quarter worth approximately $305,000. ...
https://sportsperspectives.com/2018/12/15/eiger-biopharmaceuticals-eigr-upgraded-by-valuengine-to-buy.html
No comments:
Post a Comment